Bioverge is an virtual venture capital firm and angel investing platform. We help investors discover, fund, and support the most promising life science and healthcare technology startups.
We seek disruptive companies utilizing advances in technology to modernize healthcare, from bench to bedside. We are proud to have invested in disruptive companies whose technological advancements and personalized medicine vision have the potential to extend life and drastically optimize and expand healthcare treatment options.
Investing in novel science and technology is inherently risky
- To identify the best opportunities for our community, Bioverge has developed a Dynamic Diligence process and algorithm, which analyzes key investment readiness metrics, opportunity-specific challenges, and input from subject matter experts to evaluate each opportunity on a risk-adjusted basis.
Only the highest quality and transparent opportunities are passed along to our community for evaluation
- The Bioverge community offers angel investors the chance to review vetted, transparent opportunities to invest alongside seasoned professionals at established investment terms.
- In addition to our deep screening, investors receive detailed information and tools to individually vet each deal, including opportunities to engage with the company and domain experts within the Bioverge community.
Investors inclined to participate can do so within comfort levels
- Bioverge provides access with low investment minimums. Investors can choose between single company investments or diversification using Bioverge multi-company funds.
Disrupting healthcare, together
- The pathway to market for life science and healthcare technologies is unique and often riddled with hurdles. To optimize each company’s trajectory, Bioverge community support extends beyond the deal.
- Bioverge members are passionate about improving healthcare and have extensive technical/domain expertise, as well as vast industry and later-stage financing connections.
- Investors and companies alike benefit from a multidisciplinary ecosystem with tools in place to increase engagement, advise, network, and otherwise support community companies.
Invest in the future of healthcare
- To gain access to our exclusive deal flow automatically, we encourage you to back the @Bioverge syndicate. You can sever your relationship with us at any time, and choose to not invest in any deal for any reason.
- For more information on our approach and current areas of interest:
- - Sign up for our newsletter: www.bioverge.com
- Follow us on Twitter: https://twitter.com/biovergehq
- Follow us on Medium: https://medium.com/@Bioverge
Please note: Angel investing in technology startups is risky. There is a meaningful chance that a company will fail and return no money back to investors. Even with a successful company, investors should be prepared to have their capital committed for up to 10 years without liquidity.
We syndicate our deal flow through AngelList when it's appropriate for the founders we are supporting. Our deals are highly curated and must pass the investment process outlined above prior to syndication.